Literature DB >> 23181700

Locked nucleic acid and aptamers.

Kasper K Karlsen1, Jesper Wengel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23181700      PMCID： PMC3507520          DOI： 10.1089/nat.2012.0382

Source DB:  PubMed          Journal:  Nucleic Acid Ther        ISSN： 2159-3337            Impact factor:   5.486


× No keyword cloud information.
  35 in total

Review 1.  BNAs: novel nucleic acid analogs with a bridged sugar moiety.

Authors:  Takeshi Imanishi; Satoshi Obika
Journal:  Chem Commun (Camb)       Date:  2002-08-21       Impact factor: 6.222

2.  Properties of an LNA-modified ricin RNA aptamer.

Authors:  Charlotte Förster; Martin Zydek; Maika Rothkegel; Zhiyang Wu; Claudia Gallin; Reinhard Geßner; Fred Lisdat; Jens P Fürste
Journal:  Biochem Biophys Res Commun       Date:  2012-02-03       Impact factor: 3.575

3.  Selection of smart aptamers by methods of kinetic capillary electrophoresis.

Authors:  Andrei P Drabovich; Maxim Berezovski; Victor Okhonin; Sergey N Krylov
Journal:  Anal Chem       Date:  2006-05-01       Impact factor: 6.986

4.  Semi-automated selection of DNA aptamers using magnetic particle handling.

Authors:  Aniela Wochner; Birgit Cech; Marcus Menger; Volker A Erdmann; Jörn Glökler
Journal:  Biotechniques       Date:  2007-09       Impact factor: 1.993

Review 5.  Therapeutic applications of DNA and RNA aptamers.

Authors:  Kristina W Thiel; Paloma H Giangrande
Journal:  Oligonucleotides       Date:  2009-09

6.  One round of SELEX for the generation of DNA aptamers directed against KLK6.

Authors:  Steve Arnold; Georgios Pampalakis; Kalliopi Kantiotou; Dilson Silva; Celia Cortez; Sotiris Missailidis; Georgia Sotiropoulou
Journal:  Biol Chem       Date:  2012-04       Impact factor: 3.915

Review 7.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

8.  Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors.

Authors:  Justin P Dassie; Xiu-Ying Liu; Gregory S Thomas; Ryan M Whitaker; Kristina W Thiel; Katie R Stockdale; David K Meyerholz; Anton P McCaffrey; James O McNamara; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2009-08-23       Impact factor: 54.908

9.  Efficient enzymatic synthesis of LNA-modified DNA duplexes using KOD DNA polymerase.

Authors:  Rakesh N Veedu; Birte Vester; Jesper Wengel
Journal:  Org Biomol Chem       Date:  2009-02-24       Impact factor: 3.876

10.  Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist.

Authors:  Dirk Eulberg; Klaus Buchner; Christian Maasch; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2005-03-03       Impact factor: 16.971
View more
  10 in total

Review 1.  The Toolbox for Modified Aptamers.

Authors:  Sergey A Lapa; Alexander V Chudinov; Edward N Timofeev
Journal:  Mol Biotechnol       Date:  2016-02       Impact factor: 2.695

Review 2.  In vitro selection of BNA (LNA) aptamers.

Authors:  Masayasu Kuwahara; Satoshi Obika
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

3.  Nuclease Hydrolysis Does Not Drive the Rapid Signaling Decay of DNA Aptamer-Based Electrochemical Sensors in Biological Fluids.

Authors:  Alexander Shaver; Nandini Kundu; Brian E Young; Philip A Vieira; Jonathan T Sczepanski; Netzahualcóyotl Arroyo-Currás
Journal:  Langmuir       Date:  2021-04-20       Impact factor: 3.882

Review 4.  Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.

Authors:  Joy Sebastian Prakash; Karunanithi Rajamanickam
Journal:  Biomedicines       Date:  2015-09-01

Review 5.  Chemical Modification of Aptamers for Increased Binding Affinity in Diagnostic Applications: Current Status and Future Prospects.

Authors:  Jan P Elskens; Joke M Elskens; Annemieke Madder
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

6.  Synthesis and Excellent Duplex Stability of Oligonucleotides Containing 2'-Amino-LNA Functionalized with Galactose Units.

Authors:  Rajesh Kumar; Annika Ries; Jesper Wengel
Journal:  Molecules       Date:  2017-05-21       Impact factor: 4.411

7.  DNA aptamer S11e recognizes fibrosarcoma and acts as a tumor suppressor.

Authors:  Yunyi Liu; Cheng Peng; Hui Zhang; Juan Li; Hailong Ou; Yang Sun; Chaoqi Wen; Dan Qi; Xiaoxiao Hu; Erxi Wu; Weihong Tan
Journal:  Bioact Mater       Date:  2021-10-15

8.  Molecular Recognition and In-Vitro-Targeted Inhibition of Renal Cell Carcinoma Using a DNA Aptamer.

Authors:  Hui Zhang; Zhibo Wang; Lin Xie; Yibin Zhang; Tanggang Deng; Jianglin Li; Jing Liu; Wei Xiong; Lei Zhang; Lin Zhang; Bo Peng; Leye He; Mao Ye; Xiaoxiao Hu; Weihong Tan
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-04       Impact factor: 8.886

Review 9.  Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases.

Authors:  Qin Pan; Fengling Luo; Min Liu; Xiao-Lian Zhang
Journal:  J Infect       Date:  2018-05-07       Impact factor: 6.072

Review 10.  Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts.

Authors:  Farhana Mollah; Pegah Varamini
Journal:  Biomedicines       Date:  2021-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.